期刊文献+

卡维地洛的药理学特性和临床治疗意义

原文传递
导出
摘要 卡维地洛是一种无内在拟交感活性的第三代非选择性β受体阻断药,还具有α1受体阻断、抗氧化、抗调亡及钙拮抗性质,有良好的心脏保护作用,在心血管疾病治疗中有广泛的应用前景。
机构地区 寿光市侯镇医院
出处 《医用放射技术杂志》 2006年第4期5-7,共3页 Journal of Medical Radiology Technology
  • 相关文献

参考文献12

二级参考文献33

  • 1吴彦,徐成斌.大鼠心肌反复短暂缺血再灌注损伤时的心律失常观察[J].心电学杂志,1995,14(4):231-232. 被引量:2
  • 2吴彦,徐成斌.大鼠心肌反复短暂缺血再灌注损伤时β-肾上腺素受体的变化[J].北京医科大学学报,1996,28(3):232-232. 被引量:1
  • 3[1]Wencker D, Chandra M, Nguyen K, etal. A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest,2003,111(10): 1497-1504
  • 4[5]Gheorghiade M, Bonow RO. Introduction and overview:beta-blocker therapy in the management of chronic heart failure. Am J Med, 2001, 110(Suppl7): 1S-5S
  • 5[6]Kukin ML, Kalman J, Charney RH, et al. Prospective,randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms,exercise,ejection fraction, and oxidative stress in heart failure. Circulation, 1999,99(20): 2645-2651
  • 6[7]McTavish D, Campoi-Richards D, Sorkin EM. Carvedilol:a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs, 1993,45 (2):232-258
  • 7[8]Ruffolo RR Jr, Feuerstein GZ, Ohlstein EH, et al. Recent observer vations with β-adrenoceptor blockade. AM J Hyper, 1998,11(1) :9S-14S
  • 8[9]Richards AM, Doughty R, Nicholls MG, et al. Nerurohumoral prediction of benefit from carvedilolin ischemic left ventricular dysfunction. Circulation, 1999,99 (6): 786 -792
  • 9Hansson L,Hedner T,Dahlof B.Prospective randomized open blinded end-point(PROBE)study.A novel design for intervention trials.Prospective Randomized Open Blinded End-Point.Blood Press,1992,1:113-119.
  • 10Metra M,Nodari S,D′Aloia A,et al.Effects of neurohormonal antagonism on symptoms and quality-of-life in heart failure.Eur Heart J,1998,19(Suppl B):B25-B35.

共引文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部